Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis
Recruiting
Observational Study
Cirrhosis and Chronic Liver Disease
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 2,200 (estimated)
- Sponsor
- Singapore General Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to identify factors that predict the development of decompensation, acute-on-chronic liver failure (ACLF) and death in patients with liver cirrhosis. Clinical data will be retrieved from existing hospital records. This information may help doctors to identify patients with cirrhosis who are at risk of deterioration earlier (before they develop complications) and to dev…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Patients with clinical diagnosis of liver cirrhosis
2. Age 18 years and above (parental consent required if below 21 years)
3. Willing and able to provide informed consent
Exclusion Criteria:
* No clinical evidence of liver cirrhosis
* Not willing to provide informed consen…
Contacts